FHAD1
geneOn this page
Also known as KIAA1937
Summary
FHAD1 (forkhead associated phosphopeptide binding domain 1, HGNC:29408) is a protein-coding gene on chromosome 1p36.21, encoding Forkhead-associated domain-containing protein 1 (B1AJZ9). Regulator of sperm motility and spermatocyte meiosis.
Predicted to act upstream of or within apoptotic process and spermatogenesis. Located in sperm flagellum.
Source: NCBI Gene 114827 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 236 total — 1 likely-pathogenic
- MANE Select transcript:
NM_001391957
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29408 |
| Approved symbol | FHAD1 |
| Name | forkhead associated phosphopeptide binding domain 1 |
| Location | 1p36.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1937 |
| Ensembl gene | ENSG00000142621 |
| Ensembl biotype | protein_coding |
| OMIM | 620889 |
| Entrez | 114827 |
Gene structure
Transcript identifiers
Ensembl transcripts: 26 — 13 protein_coding, 8 protein_coding_CDS_not_defined, 4 retained_intron, 1 nonsense_mediated_decay
ENST00000314668, ENST00000358897, ENST00000375995, ENST00000375996, ENST00000375997, ENST00000375998, ENST00000433640, ENST00000444385, ENST00000459961, ENST00000462113, ENST00000471347, ENST00000472086, ENST00000472131, ENST00000472449, ENST00000477846, ENST00000481324, ENST00000483120, ENST00000483694, ENST00000495195, ENST00000524761, ENST00000529606, ENST00000532408, ENST00000683790, ENST00000688493, ENST00000940095, ENST00000968213
RefSeq mRNA: 2 — MANE Select: NM_001391957
NM_001391957, NM_052929
CCDS: CCDS90866
Canonical transcript exons
ENST00000688493 — 34 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001635046 | 15374502 | 15374631 |
| ENSE00001663227 | 15301205 | 15301441 |
| ENSE00001684628 | 15296684 | 15296793 |
| ENSE00001763069 | 15289399 | 15289666 |
| ENSE00001769396 | 15272323 | 15272529 |
| ENSE00003461440 | 15349042 | 15349149 |
| ENSE00003461727 | 15391210 | 15391263 |
| ENSE00003462723 | 15345416 | 15345523 |
| ENSE00003484579 | 15329346 | 15329541 |
| ENSE00003490890 | 15308613 | 15308736 |
| ENSE00003509575 | 15362642 | 15362726 |
| ENSE00003522950 | 15358110 | 15358283 |
| ENSE00003527950 | 15375603 | 15375730 |
| ENSE00003540539 | 15365827 | 15365933 |
| ENSE00003551683 | 15382028 | 15382193 |
| ENSE00003556144 | 15369370 | 15369502 |
| ENSE00003561984 | 15360478 | 15360703 |
| ENSE00003602992 | 15367463 | 15367622 |
| ENSE00003614203 | 15313057 | 15313187 |
| ENSE00003647179 | 15327059 | 15327142 |
| ENSE00003652902 | 15381231 | 15381451 |
| ENSE00003654485 | 15317824 | 15317928 |
| ENSE00003664267 | 15380701 | 15380796 |
| ENSE00003666163 | 15324452 | 15324559 |
| ENSE00003674002 | 15251771 | 15251877 |
| ENSE00003675424 | 15316378 | 15316467 |
| ENSE00003684578 | 15345083 | 15345190 |
| ENSE00003686353 | 15352877 | 15352984 |
| ENSE00003788031 | 15328277 | 15328429 |
| ENSE00003916780 | 15341736 | 15341888 |
| ENSE00003917332 | 15388051 | 15388131 |
| ENSE00003918246 | 15397297 | 15398328 |
| ENSE00003921997 | 15339481 | 15339551 |
| ENSE00003925918 | 15247223 | 15247395 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 96.57.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0957 / max 53.0858, expressed in 359 samples.
FANTOM5 promoters (11 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 821 | 0.3368 | 149 |
| 822 | 0.1774 | 86 |
| 829 | 0.1583 | 57 |
| 831 | 0.1376 | 72 |
| 837 | 0.0728 | 31 |
| 836 | 0.0464 | 15 |
| 838 | 0.0414 | 19 |
| 830 | 0.0401 | 10 |
| 832 | 0.0329 | 13 |
| 834 | 0.0303 | 15 |
Top tissues by expression
236 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 96.57 | gold quality |
| bronchial epithelial cell | CL:0002328 | 94.91 | gold quality |
| bronchus | UBERON:0002185 | 93.45 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 90.70 | gold quality |
| left testis | UBERON:0004533 | 89.62 | gold quality |
| right testis | UBERON:0004534 | 89.15 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.84 | gold quality |
| testis | UBERON:0000473 | 86.58 | gold quality |
| oviduct epithelium | UBERON:0004804 | 82.40 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 81.48 | gold quality |
| buccal mucosa cell | CL:0002336 | 81.24 | gold quality |
| fallopian tube | UBERON:0003889 | 80.37 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.49 | gold quality |
| endothelial cell | CL:0000115 | 71.66 | gold quality |
| right lung | UBERON:0002167 | 69.58 | gold quality |
| endocervix | UBERON:0000458 | 68.72 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 68.19 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 67.91 | gold quality |
| prefrontal cortex | UBERON:0000451 | 67.87 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.65 | gold quality |
| sural nerve | UBERON:0015488 | 67.46 | gold quality |
| upper lobe of lung | UBERON:0008948 | 67.19 | gold quality |
| caput epididymis | UBERON:0004358 | 66.87 | gold quality |
| left uterine tube | UBERON:0001303 | 66.68 | gold quality |
| hypothalamus | UBERON:0001898 | 66.63 | gold quality |
| bone marrow cell | CL:0002092 | 66.30 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 66.17 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 65.84 | gold quality |
| thyroid gland | UBERON:0002046 | 65.81 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 65.72 | silver quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.62 |
| E-GEOD-130148 | yes | 11.31 |
| E-MTAB-8060 | no | 36.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting FHAD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-8087 | 99.90 | 69.55 | 1351 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-7161-5P | 99.68 | 68.92 | 1592 |
| HSA-MIR-548U | 99.65 | 67.78 | 1463 |
| HSA-MIR-26A-1-3P | 99.64 | 66.81 | 788 |
| HSA-MIR-26A-2-3P | 99.64 | 66.82 | 786 |
| HSA-MIR-425-5P | 99.59 | 67.67 | 900 |
| HSA-MIR-513C-5P | 99.50 | 68.42 | 1730 |
| HSA-MIR-514B-5P | 99.50 | 68.19 | 1766 |
| HSA-MIR-519D-5P | 99.41 | 69.30 | 2057 |
| HSA-MIR-5695 | 99.41 | 67.48 | 1047 |
| HSA-MIR-6882-5P | 99.35 | 71.13 | 1206 |
| HSA-MIR-642A-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-642B-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-4464 | 98.95 | 67.73 | 820 |
| HSA-MIR-4748 | 98.95 | 67.53 | 810 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-4755-3P | 98.77 | 65.59 | 1915 |
| HSA-MIR-16-1-3P | 98.70 | 69.23 | 1538 |
| HSA-MIR-4266 | 98.53 | 67.29 | 1035 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fhad1 | ENSDARG00000056723 |
| danio_rerio | si:dkey-163f12.6 | ENSDARG00000094473 |
| mus_musculus | Fhad1 | ENSMUSG00000051435 |
| rattus_norvegicus | Fhad1 | ENSRNOG00000028064 |
Paralogs (1): CCDC27 (ENSG00000162592)
Protein
Protein identifiers
Forkhead-associated domain-containing protein 1 — B1AJZ9 (reviewed: B1AJZ9)
All UniProt accessions (10): B1AJZ9, A0A804HIA4, H0Y3C6, H0Y5P0, H0Y605, H0YCR1, H0YE38, H0YEU3, Q5JYW1, Q5JYW6
UniProt curated annotations — full annotation on UniProt →
Function. Regulator of sperm motility and spermatocyte meiosis.
Subcellular location. Cell projection. Cilium. Flagellum.
Tissue specificity. Testis (at protein level).
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| B1AJZ9-1 | 1 | yes |
| B1AJZ9-3 | 3 | |
| B1AJZ9-4 | 4 |
RefSeq proteins (2): NP_001378886, NP_443161 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000253 | FHA_dom | Domain |
| IPR008984 | SMAD_FHA_dom_sf | Homologous_superfamily |
| IPR052642 | CC-FHA_domain | Family |
Pfam: PF00498
UniProt features (22 total): coiled-coil region 5, compositionally biased region 5, region of interest 5, splice variant 2, sequence conflict 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B1AJZ9-F1 | 71.77 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 56 (showing top):
BROWN_MYELOID_CELL_DEVELOPMENT_UP, LEIN_CHOROID_PLEXUS_MARKERS, GOCC_MOTILE_CILIUM, GOCC_CILIUM, DODD_NASOPHARYNGEAL_CARCINOMA_DN, chr1p36, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D, RATTENBACHER_BOUND_BY_CELF1, GOCC_9PLUS2_MOTILE_CILIUM, FOXN3_TARGET_GENES, HAND1_TARGET_GENES, HDAC4_TARGET_GENES, HES2_TARGET_GENES, NFE2L1_TARGET_GENES, TOP2B_TARGET_GENES
GO Biological Process (2): apoptotic process (GO:0006915), spermatogenesis (GO:0007283)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): sperm flagellum (GO:0036126), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| binding | 1 |
| 9+2 motile cilium | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
466 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FHAD1 | KLHL8 | Q9P2G9 | 668 |
| FHAD1 | PI15 | O43692 | 540 |
| FHAD1 | ATP11A | P98196 | 507 |
| FHAD1 | ZNF407 | Q9C0G0 | 499 |
| FHAD1 | SUSD4 | Q5VX71 | 495 |
| FHAD1 | SEL1L3 | Q68CR1 | 490 |
| FHAD1 | TTC34 | A8MYJ7 | 484 |
| FHAD1 | FAM181B | A6NEQ2 | 452 |
| FHAD1 | OR5J2 | Q8NH18 | 448 |
| FHAD1 | OR1N2 | Q8NGR9 | 448 |
| FHAD1 | BCAS3 | Q9H6U6 | 446 |
| FHAD1 | LRRC38 | Q5VT99 | 426 |
| FHAD1 | HEPHL1 | Q6MZM0 | 423 |
| FHAD1 | GLDC | P23378 | 418 |
| FHAD1 | TMEM101 | Q96IK0 | 411 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FHAD1 | HIST2H2BF | psi-mi:“MI:0915”(physical association) | 0.400 |
| NEFM | FHAD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KLF8 | psi-mi:“MI:0914”(association) | 0.350 | |
| EPHA3 | FHAD1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (14): HIST2H2BF (Proximity Label-MS), HIST1H2BH (Proximity Label-MS), FHAD1 (Affinity Capture-MS), FHAD1 (Affinity Capture-MS), FHAD1 (Affinity Capture-MS), FHAD1 (Affinity Capture-MS), FHAD1 (Affinity Capture-MS), FHAD1 (Affinity Capture-MS), FHAD1 (Affinity Capture-MS), FHAD1 (Cross-Linking-MS (XL-MS)), FHAD1 (Cross-Linking-MS (XL-MS)), ALOX12B (Cross-Linking-MS (XL-MS)), FHAD1 (Cross-Linking-MS (XL-MS)), FHAD1 (Proximity Label-MS)
ESM2 similar proteins: A0JMQ7, A0JMY4, A2AUM9, A2BDR7, A2BGP7, A6NI79, A6PWD2, A6QNP9, B1AJZ9, D3YV10, G9G127, O35550, O35551, O75330, O94986, P0CB05, Q05D60, Q0VFN8, Q0VFX2, Q15276, Q17QT2, Q3UPP8, Q498G2, Q4KLY0, Q4PJT6, Q4R703, Q4V7B0, Q5JU67, Q5NVN6, Q5U3A8, Q5U3Z6, Q5U4W1, Q5ZL12, Q66KE8, Q6DFC2, Q6DIS8, Q6IMY1, Q6NRC9, Q6P402, Q7M6Y5
Diamond homologs: A6PWD2, B1AJZ9, P66800, P9WGJ8, P9WGJ9, Q80U49, Q9Y4F5, A0QNG6, A0QYG2, B7SY83, O65934, P46014, P46017, P64898, P9WJA8, P9WJA9, P9WJB4, P9WJB5, Q4JVU0, Q6NHD4, Q8FTJ5, Q8NQJ3, Q9FIK2, A0JM08, Q498L0, Q5M9G6, Q5SW79, Q6A065, Q8BIZ6, Q8TAD8, Q8W4D8, Q96L14, Q9BWU0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
236 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 195 |
| Likely benign | 17 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 149960 | GRCh38/hg38 1p36.21(chr1:13400935-15356944)x1 | Likely pathogenic |
SpliceAI
5951 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:15247391:GCCAG:G | donor_gain | 1.0000 |
| 1:15251873:TACAG:T | donor_loss | 1.0000 |
| 1:15251874:ACAG:A | donor_loss | 1.0000 |
| 1:15251876:AG:A | donor_loss | 1.0000 |
| 1:15251877:GG:G | donor_loss | 1.0000 |
| 1:15251878:GT:G | donor_loss | 1.0000 |
| 1:15251879:T:A | donor_loss | 1.0000 |
| 1:15272321:A:AG | acceptor_gain | 1.0000 |
| 1:15272322:G:GG | acceptor_gain | 1.0000 |
| 1:15272528:CGG:C | donor_loss | 1.0000 |
| 1:15272530:G:GC | donor_loss | 1.0000 |
| 1:15272530:G:GG | donor_gain | 1.0000 |
| 1:15272531:TGA:T | donor_loss | 1.0000 |
| 1:15272532:GAG:G | donor_loss | 1.0000 |
| 1:15289662:GCAAG:G | donor_gain | 1.0000 |
| 1:15289665:AGGTA:A | donor_loss | 1.0000 |
| 1:15289666:GG:G | donor_loss | 1.0000 |
| 1:15289667:GT:G | donor_loss | 1.0000 |
| 1:15289668:T:A | donor_loss | 1.0000 |
| 1:15296668:T:A | acceptor_gain | 1.0000 |
| 1:15308612:GATCA:G | acceptor_gain | 1.0000 |
| 1:15312129:G:T | donor_gain | 1.0000 |
| 1:15327051:T:TA | acceptor_gain | 1.0000 |
| 1:15327054:T:A | acceptor_gain | 1.0000 |
| 1:15327055:GCAGC:G | acceptor_loss | 1.0000 |
| 1:15327057:A:AG | acceptor_gain | 1.0000 |
| 1:15327058:G:GG | acceptor_gain | 1.0000 |
| 1:15327058:GCT:G | acceptor_gain | 1.0000 |
| 1:15327143:G:GA | donor_loss | 1.0000 |
| 1:15327143:G:GG | donor_gain | 1.0000 |
AlphaMissense
9859 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:15251798:T:C | L5P | 0.997 |
| 1:15272347:G:C | A40P | 0.997 |
| 1:15272392:G:C | D55H | 0.997 |
| 1:15272393:A:C | D55A | 0.997 |
| 1:15272420:T:A | V64D | 0.997 |
| 1:15272348:C:A | A40E | 0.996 |
| 1:15272387:T:C | L53P | 0.996 |
| 1:15272456:T:A | L76H | 0.996 |
| 1:15381343:G:C | R1283P | 0.996 |
| 1:15272351:T:C | L41P | 0.995 |
| 1:15272387:T:A | L53H | 0.995 |
| 1:15251846:G:A | G21E | 0.994 |
| 1:15272354:T:A | I42N | 0.994 |
| 1:15272393:A:G | D55G | 0.994 |
| 1:15272394:C:A | D55E | 0.994 |
| 1:15272394:C:G | D55E | 0.994 |
| 1:15272423:A:T | N65I | 0.994 |
| 1:15272456:T:C | L76P | 0.994 |
| 1:15272393:A:T | D55V | 0.993 |
| 1:15272474:T:C | L82P | 0.992 |
| 1:15272479:T:C | F84L | 0.992 |
| 1:15272481:T:A | F84L | 0.992 |
| 1:15272481:T:G | F84L | 0.992 |
| 1:15381355:T:C | L1287P | 0.992 |
| 1:15251843:T:A | I20N | 0.991 |
| 1:15272414:C:A | T62K | 0.991 |
| 1:15272416:T:C | F63L | 0.991 |
| 1:15272418:T:A | F63L | 0.991 |
| 1:15272418:T:G | F63L | 0.991 |
| 1:15272480:T:C | F84S | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000022013 (1:15252997 T>C), RS1000053098 (1:15375285 C>G), RS1000063159 (1:15334086 A>G,T), RS1000074432 (1:15297267 G>A,T), RS1000090329 (1:15289279 T>C), RS1000090748 (1:15337553 T>C,G), RS1000095550 (1:15334318 G>A), RS1000117157 (1:15370679 C>G), RS1000169729 (1:15380933 T>C), RS1000177528 (1:15270556 T>C), RS1000178066 (1:15326266 C>T), RS1000181293 (1:15258831 G>A,T), RS1000191855 (1:15269253 T>G), RS1000197308 (1:15390032 T>C), RS1000216158 (1:15310114 A>C,G)
Disease associations
OMIM: gene MIM:620889 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003226_3 | Pelvic organ prolapse | 7.000000e-07 |
| GCST003560_7 | Coronary artery aneurysm in Kawasaki disease | 1.000000e-06 |
| GCST004860_120 | Alcoholic chronic pancreatitis | 6.000000e-06 |
| GCST004860_132 | Alcoholic chronic pancreatitis | 2.000000e-10 |
| GCST004860_133 | Alcoholic chronic pancreatitis | 8.000000e-09 |
| GCST004860_18 | Alcoholic chronic pancreatitis | 1.000000e-07 |
| GCST004860_43 | Alcoholic chronic pancreatitis | 3.000000e-22 |
| GCST004860_67 | Alcoholic chronic pancreatitis | 8.000000e-10 |
| GCST004860_68 | Alcoholic chronic pancreatitis | 2.000000e-07 |
| GCST009377_9 | Bone mineral density | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007620 | volumetric bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, increases methylation | 2 |
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| Silicon Dioxide | decreases expression, increases expression | 2 |
| Smoke | increases abundance, increases expression, decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| dimethylselenide | increases expression, increases oxidation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Methapyrilene | increases methylation | 1 |
| Ozone | increases oxidation, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | affects methylation | 1 |
| Hydroxyl Radical | increases expression, increases oxidation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D8LD | Ubigene HCT 116 FHAD1 KO | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): coronary aneurysm, pelvic organ prolapse